PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,113,000 | -23.6% | 1,300,000 | 0.0% | 2.12% | -15.2% |
| Q2 2021 | $11,934,000 | -5.6% | 1,300,000 | 0.0% | 2.50% | -4.2% |
| Q1 2021 | $12,636,000 | -5.3% | 1,300,000 | 0.0% | 2.61% | +20.6% |
| Q4 2020 | $13,338,000 | +19.9% | 1,300,000 | +18.0% | 2.17% | +116.6% |
| Q3 2020 | $11,120,000 | +1052.3% | 1,102,073 | +1091.4% | 1.00% | +1198.7% |
| Q2 2020 | $965,000 | -97.2% | 92,502 | -89.7% | 0.08% | -97.8% |
| Q1 2019 | $34,911,000 | +24.3% | 900,000 | -34.8% | 3.46% | -2.6% |
| Q4 2018 | $28,077,000 | -99.9% | 1,379,700 | +175.9% | 3.55% | -29.8% |
| Q1 2018 | $34,025,000,000 | – | 500,000 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |